Viva Hydration Boost

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the temporary relief of burning and irritation due to dryness of the eye. It is also indicated for the temporary relief of discomfort resulting from minor irritations of the eye or exposure to environmental factors such as wind or sun. Additionally, this drug serves as a protectant against further irritation and provides temporary relief from dryness of the eye.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Glycerin 0.25% is indicated for ocular use. Healthcare professionals should instruct patients to instill 1 or 2 drops of the solution into the affected eye(s) as needed. The frequency of administration may be adjusted based on the patient's condition and response to treatment. It is essential to ensure that the dropper tip does not come into contact with any surface, including the eye, to maintain sterility and prevent contamination.

Contraindications

Use of this product is contraindicated in the following situations:

The solution should not be used if it has changed color or become cloudy, as this may indicate degradation or contamination. Additionally, the product must not be used if the tamper-evident ring is broken or missing, as this compromises the integrity of the product.

Patients should discontinue use and consult a healthcare professional if they experience eye pain, changes in vision, continued redness or irritation of the eye, or if the condition worsens or persists for more than 72 hours.

During use, it is essential to avoid touching the tip of the container to any surface to prevent contamination.

Warnings and Precautions

For external use only. In the event of accidental ingestion, it is imperative to seek medical assistance or contact a Poison Control Center immediately.

The product should not be used if the solution exhibits any changes in color or becomes cloudy. Additionally, if the tamper-evident ring is broken or missing, the product should not be used, as this may indicate potential contamination or compromise of the product's integrity.

Healthcare professionals should advise patients to discontinue use and consult a physician if they experience any of the following symptoms: eye pain, changes in vision, persistent redness or irritation of the eye, or if the condition worsens or persists for more than 72 hours. Monitoring for these symptoms is essential to ensure patient safety and effective management of any adverse reactions.

Side Effects

Patients should be aware that the product is intended for external use only.

In clinical practice, if patients experience any of the following symptoms, they are advised to discontinue use and consult a healthcare professional: eye pain, changes in vision, continued redness or irritation of the eye, or if the condition worsens or persists for more than 72 hours. These reactions warrant immediate medical attention to ensure patient safety and appropriate management.

Drug Interactions

There are currently no documented drug interactions associated with the use of this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Viva Hydration Boost (glycerin). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should use this medication for external application only. The recommended dosage is to instill 1 or 2 drops in the affected eye(s) as needed.

Healthcare professionals should advise caregivers to monitor for any adverse symptoms. If pediatric patients experience eye pain, changes in vision, continued redness or irritation of the eye, or if the condition worsens or persists for more than 72 hours, the medication should be discontinued, and a doctor should be consulted.

In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any potential adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

There is no specific information regarding the use of this medication during pregnancy, including safety concerns, dosage modifications, or special precautions. Healthcare professionals should consider the lack of data when prescribing this medication to pregnant patients. It is advisable to weigh the potential benefits against any unknown risks to fetal outcomes. Women of childbearing potential should be counseled on the importance of effective contraception during treatment.

Lactation

There are no specific warnings or recommendations regarding nursing mothers. Additionally, there are no specific considerations or precautions related to lactation. Therefore, healthcare professionals may not need to take special precautions when prescribing this medication to lactating mothers.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

There is currently no specific information available regarding overdosage for this medication. Healthcare professionals are advised to monitor patients closely for any signs of adverse effects or symptoms that may arise from excessive dosing.

In the event of suspected overdosage, it is recommended that healthcare providers initiate supportive care and symptomatic treatment as necessary. Patients should be evaluated for potential complications, and appropriate interventions should be implemented based on the clinical presentation.

For further guidance, healthcare professionals should refer to established protocols and consult relevant toxicology resources.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data in these areas limits the understanding of the compound's potential effects in nonclinical settings.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Patients should be advised to seek immediate medical assistance or contact a Poison Control Center if the product is swallowed. Healthcare providers should instruct patients to monitor the solution for any changes in color or clarity, as such changes may indicate a problem with the product.

It is important to inform patients that they should not use the product if the tamper-evident ring is broken or missing, as this may compromise the safety and integrity of the medication. Patients should be counseled to discontinue use and consult a doctor if they experience any eye pain, changes in vision, persistent redness or irritation of the eye, or if their condition worsens or does not improve after 72 hours.

Healthcare providers should emphasize the importance of avoiding contamination by instructing patients not to touch the tip of the container to any surface. Additionally, patients should be reminded to securely replace the cap after each use to maintain the product's efficacy and safety.

Storage and Handling

The product is supplied in packaging that includes a LOT number and expiration date, which can be found on the bottom of both the box and the bottle. It is essential to store the product at a temperature range of 15-25ºC (55-77ºF) to ensure its stability and efficacy. Proper handling and storage conditions must be adhered to in order to maintain the integrity of the product.

Additional Clinical Information

Patients should instill 1 or 2 drops in the affected eye(s) as needed. It is important to note that the solution is for external use only. Patients are advised to discontinue use and consult a doctor if they experience eye pain, changes in vision, continued redness or irritation, or if the condition worsens or persists for more than 72 hours.

Additionally, patients should be informed to seek medical help or contact a Poison Control Center immediately if the solution is swallowed. To ensure safety and efficacy, patients should avoid touching the tip of the container to any surface to prevent contamination, replace the cap after use, and be aware of any changes in the solution's color or clarity, as well as the integrity of the tamper-evident ring.

Drug Information (PDF)

This file contains official product information for Viva Hydration Boost, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)